◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Nipro Corporation (8086)

Name: Nipro Corporation（8086）— 財務諸表の推移
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

公式財務諸表に基づく売上高、利益、キャッシュフローの推移。

Healthcare · ウォール街（米国） · 最終更新: 2026-10-02

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses worldwide. The company offers renal products; interventional products, such as cardiovascular products, endovascular products, and accessories; and hospital products, including hypodermic needles, syringes, IV sets and catheters, 3-way stopcocks, infusion sets, balloon infusers, etc.

主要指標

時価総額: JPY 213 billion
売上高（2026-03-31 期末の会計年度）: JPY 660.5B
当期純利益: JPY 13.5B
売上総利益率: 31.5%
純利益率: 2.0%

インタラクティブチャートと全財務諸表を見る → バリュエーションモデル（DCF）→

年次損益計算書

損益計算書	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
売上高合計	JPY 660.5B	JPY 644.6B	JPY 586.8B	JPY 545.2B	—
売上総利益	JPY 208.3B	JPY 190.9B	JPY 171.3B	JPY 163.4B	—
営業利益（EBIT）	JPY 37.6B	JPY 26.6B	JPY 22.3B	JPY 17.7B	—
当期純利益	JPY 13.5B	JPY 5.1B	JPY 11.1B	JPY 4.6B	—

出典: 企業の公開資料（SEC）。数値をご利用の前に SEC EDGAR でご確認ください。

貸借対照表、キャッシュフロー計算書、四半期データおよび全財務比率は 8086 のインタラクティブ・ビューアーでご覧いただけます。 /companies/us/8086

類似企業

本サイトの情報は教育および情報提供のみを目的としており、投資助言ではありません。目標株価や投資判断は掲載していません。

English version →全銘柄

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.